Page last updated: 2024-11-05

tolbutamide and Parkinsonian Disorders

tolbutamide has been researched along with Parkinsonian Disorders in 3 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HELLER, GL1
DEJONG, RN1
MAGEE, KR1
SCHWARTZ, W1
Brown, JD1
Stone, DB1

Other Studies

3 other studies available for tolbutamide and Parkinsonian Disorders

ArticleYear
Tolbutamide in the treatment of parkinsonism.
    JAMA, 1961, Apr-15, Volume: 176

    Topics: Parkinson Disease; Parkinsonian Disorders; Tolbutamide

1961
MEBUTAMATE AND HYDROCHLOROTHIAZIDE IN HYPERTENSION.
    Journal of the American Geriatrics Society, 1964, Volume: 12

    Topics: Antihypertensive Agents; Arthritis; Arthritis, Rheumatoid; Blood Pressure Determination; Carbamates;

1964
TOLBUTAMIDE-INDUCED HYPOGLYCEMIA.
    The American journal of clinical nutrition, 1964, Volume: 15

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Chlorpropamide; Diabetes Mellitus; Drug Therapy; Female;

1964